London, England, United Kingdom The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the London.
Among the various public portfolio startups of the fund, we may underline Cullinan Oncology, Cullinan Oncology, Causemo Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are CleanTech, Biopharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Comparing to the other companies, this Park Vale Capital performs on 4 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2017. The increased amount of exits for fund were in 2019.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Park Vale Capital, startups are often financed by MPM Capital, F2 Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, F2 Ventures, SessionM. In the next rounds fund is usually obtained by MPM Capital, F2 Ventures.
Funds with similar focus
| Fund Name | Location |
| 9W Capital Management | - |
| aCommerce | Bangkok, Krung Thep, Thailand |
| BacktoWork | Italy, Lombardia, Milano |
| Beam Suntory | Deerfield, Illinois, United States |
| Direct Selling Capital | Dallas, Texas, United States |
| First Capital Ventures | Colorado, Greenwood Village, United States |
| Linkage Biosciences | California, San Francisco, United States |
| Newell Brands Inc. | Atlanta, Georgia, United States |
| Palmieri Family Trust | - |
| Sanwa Supply | Japan, Okayama, Okayama Prefecture |
| Shanghai Qinghong Guyi Capital Management Center | - |
| Singapore EDB | Central, Central Region, Singapore |
| Skypoint Capital | Canada, Nepean, Ontario |
| Telama Investment | - |
| The Vertical Group | Basking Ridge, New Jersey, United States |
| Tianhe Capital | China, Gansu, Lanzhou |
| Valinor Management | New York, New York, United States |
| ZD Capital | China, Guangdong, Guangzhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cullinan Oncology | $150M | 03 Oct 2017 | Cambridge, Massachusetts, United States | ||
Causemo | $4M | 25 Aug 2015 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cullinan Oncology | $150M | 03 Oct 2017 | Cambridge, Massachusetts, United States | ||
Causemo | $4M | 25 Aug 2015 | Boston, Massachusetts, United States |
